![Michael Messinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 6 493 $ in data 31/05/2026
Michael Messinger is Director at Filament Health Corp.
since 2024.
Mr. Messinger is Chief Financial Officer at Seastar Medical Holding Corp.
starting in 2025.
Formerly, Mr. Messinger was Finance Director at Lexicon Pharmaceuticals, Inc. from 2001 to 2012.
Mr. Messinger worked as Auditor at Ernst & Young LLP from 1996 to 1999.
Mr. Messinger served as Controller at Coelacanth Corp.
from 1999 to 2001.
Mr. Messinger was President, Chief Executive & Operating Officer at ContraFect Corp.
in 2023.
Mr. Messinger completed undergraduate education at the University of Michigan.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 1.750 ( 0,04% ) | 6 493 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FILAMENT HEALTH CORP. | Direttore/Membro del Consiglio | 28/03/2024 |
| SEASTAR MEDICAL HOLDING CORPORATION | Direttore Finanziario/CFO | 14/11/2025 |
| Società | Posizione | Fine |
|---|---|---|
| CONTRAFECT CORPORATION | Amministratore Delegato | 04/12/2023 |
| LEXICON PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/01/2012 |
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Researches drug development | Comptroller/Controller/Auditor | 01/01/2001 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01/01/1999 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Researches drug development | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ContraFect Corp.
 ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
Filament Health Corp.
 Filament Health Corp. Pharmaceuticals: OtherHealth Technology Develops psychedelic pharmaceuticals | Health Technology |
Seastar Medical Holding Corp.
 Seastar Medical Holding Corp. Medical SpecialtiesHealth Technology Manufactures medical devices and develops technology solutions | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
